Pharmaceutical News

RSS

KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement

KV Pharmaceutical Company ( KVa/KVb) today announced it has entered into an amendment to the existing asset purchase agreement with Hologic, Inc. to secure the full U.S. and worldwide rights to Gestiva(TM), subject to the terms and conditions set forth in the amendment. Upon approval by the U.S. Food and Drug Administration (the "FDA"), Gestiva(TM) will be the first and only FDA-approved treatment for the prevention of preterm birth in women who are pregnant with a single baby and have spontaneously delivered a single baby preterm in the past.

From Hologic, Inc. 12 Jan 2010

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

A leading clinical research center in Austin has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.

12 Jan 2010

AmerisourceBergen announces new programs for long term care and retail pharmacies

AmerisourceBergen, under its’ PRxO® Generics Solution, today announced a new program for long term care pharmacies and an expanded program for retail pharmacies. The new solutions are tailored to better meet customer needs as generic prescription demands continue to increase.

12 Jan 2010

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) National Influenza Vaccination Week (NIVW), January 10-16, 2010, which highlights the importance of annual influenza vaccination after the holiday season into January and beyond.

12 Jan 2010

Official H1N1-related death count approaches 13,000 worldwide, WHO says

H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).

12 Jan 2010

BioCryst Pharmaceuticals signs agreements with two additional partners

BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.

12 Jan 2010

Cancer drug may provide an effective secondary treatment for gut tumor

A drug that is already an approved therapy for some cancers also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, according to a team led by researchers from the University of Pittsburgh Cancer Institute (UPCI). The findings, based on experiments using cell cultures, were published in the Jan. 1 issue of Cancer Research.

12 Jan 2010

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

PhotoMedex and Galderma Laboratories, L.P. have entered into a co-promotion agreement for Galderma’s photodynamic therapy application for the treatment of actinic keratoses (“AK”).

11 Jan 2010

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis (hay fever) by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

11 Jan 2010

Los Angeles International Airport offers H1N1 flu shots in airline terminals

Los Angeles International Airport (LAX), in partnership with FLU*Ease, Inc., is now offering flu shots to travelers in most of the airline terminals as a public safety measure against the flu, especially the H1N1 strain.)

11 Jan 2010

Targacept signs collaboration and license agreement with AstraZeneca

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

11 Jan 2010

Wall Street Journal examines polio vaccinations in Afghanistan

In a story about polio vaccination campaigns in Afghanistan, the Wall Street Journal examines how the Taliban and international health agencies are working together to promote oral vaccination campaigns across the country.

11 Jan 2010

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that it has received $3.75 million in milestone payments from partner Galderma S.A.

11 Jan 2010

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.

11 Jan 2010

Meda receives exclusive rights to distribute AML drug in Europe and Asia

Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.

11 Jan 2010

EpiCept, Meda enter into exclusive commercialization agreement for Ceplene

EpiCept Corporation announced today that it has entered into an exclusive commercialization agreement for Ceplene® (histamine dihydrochloride) with Meda AB, a leading international specialty pharmaceutical company based in Stockholm. Ceplene is EpiCept’s novel therapy approved in the European Union with orphan drug status for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.

11 Jan 2010

Bryant Ranch Prepack tracks medications from its manufacture to the patient with E Pedigree

“More and more physicians are realizing that prescriptions that leave the office are like money walking out of the door,” said Fred Ganjian, Vice President of Sales and Marketing for Bryant Ranch Prepack, a leading supplier of prepackaged physician-dispensed prescription programs. “In this day of continuing pressure on physicians to cover their costs, physician-dispensed prescriptions have become increasingly important to a physician’s bottom line,” he added.

11 Jan 2010

Highmark joins with CDC to promote National Influenza Vaccination Week

Beginning Sunday, Jan. 10 and continuing through the week, Highmark Inc. will join with the Centers for Disease Control (CDC) to promote National Influenza Vaccination Week.

10 Jan 2010

AMAG Pharmaceuticals provides update on the commercial launch of Feraheme Injection

AMAG Pharmaceuticals, Inc. today provided an update on the commercial launch of Feraheme® (ferumoxytol) Injection for intravenous (IV) use, including preliminary fourth quarter 2009 Feraheme net product revenues estimates, as well as an update on the Company’s international and label expansion efforts.

10 Jan 2010

Thirteen percent of poison exposure calls related to painkillers

U.S. poison centers answered more than 4.3 million calls in 2008, including nearly 2.5 million calls about human exposures to poison, according to the American Association of Poison Control Centers -- up from 4.2 million calls in 2007.

9 Jan 2010

Pharmaceutical News

KV Pharmaceutical, Hologic amend Gestiva asset purchase agreement

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

AmerisourceBergen announces new programs for long term care and retail pharmacies

American Lung Association supports CDC's NIVW to highlight the importance influenza vaccination

Official H1N1-related death count approaches 13,000 worldwide, WHO says

BioCryst Pharmaceuticals signs agreements with two additional partners

Cancer drug may provide an effective secondary treatment for gut tumor

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Los Angeles International Airport offers H1N1 flu shots in airline terminals

Targacept signs collaboration and license agreement with AstraZeneca

Wall Street Journal examines polio vaccinations in Afghanistan

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

Meda receives exclusive rights to distribute AML drug in Europe and Asia

EpiCept, Meda enter into exclusive commercialization agreement for Ceplene

Bryant Ranch Prepack tracks medications from its manufacture to the patient with E Pedigree

Highmark joins with CDC to promote National Influenza Vaccination Week

AMAG Pharmaceuticals provides update on the commercial launch of Feraheme Injection

Thirteen percent of poison exposure calls related to painkillers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News